DRUG DEVELOPMENT RESEARCH《药物开发研究》(可官网投稿)

DRUG DEVELOPMENT RESEARCH《药物开发研究》(一年8期). Drug Development Research publishes research papers and review-type articles covering all area within drug development: from target identification and validation and structure–activity relationship studies, through to post-market clinical reports. Topics covered include but are not limited to medicinal and process chemistry, pharmacology, biotechnology and biopharmaceuticals, toxicology, drug delivery, formulation, pharmacokinetics, clinical trial reviews and post-approval/post-marketing evaluation.

杂志简称:drug develop res
中文译名:《药物开发研究》
收录属性:scie(2024版), 目次收录(维普), 目次收录(知网),英文期刊,
自引率:3.20%
投稿方向:医学、chemistry, medicinal药物化学、pharmacology & pharmacy药学

DRUG DEVELOPMENT RESEARCH《药物开发研究》

SCI/E期刊基本信息

出版周期:年8期 地区:美国
中科院分区:4区
是否TOP:非TOP期刊
是否综述:非综述期刊
是否OA:非OA期刊
国际标准刊号:ISSN0272-4391;EISSN1098-2299
杂志语言:英语
出版国家:美国

杂志官网 联系方式

出版地址:WILEY-LISS,DIV JOHN WILEY & SONS INC,111 RIVER ST,HOBOKEN,USA,NJ,07030
杂志邮箱:
投稿网址:https://mc.manuscriptcentral.com/ddr
杂志官方网址:https://onlinelibrary.wiley.com/journal/10982299
出版商网址:http://www.wiley.com/WileyCDA/

杂志投稿要求

投稿须知【杂志社官方网站信息】

Drug Development Research Author Guidelines

Sections

Submission and Peer Review Process

Article Types

After Acceptance

1. Submission and Peer Review Process

Once the submission materials have been prepared in accordance with the Author Guidelines, manuscripts should be submitted online at: https://mc.manuscriptcentral.com/ddr

For help with submissions, please contact: ddr.editorial@wiley.com

This journal does not charge submission fees.

Article Preparation Support

Wiley Editing Services offers expert help with English Language Editing, as well as translation, manuscript formatting, figure illustration, figure formatting, and graphical abstract design – so you can submit your manuscript with confidence.

Also, check out our resources for Preparing Your Article for general guidance about writing and preparing your manuscript.

Free format submission

Drug Development Research offers free format submission for a simplified and streamlined submission process.

Before you submit, you will need:

Your manuscript: this can be a single file including text, figures, and tables, or separate files—whichever you prefer. All required sections should be contained in your manuscript, including abstract, introduction, methods, results, and discussion. Figures and tables should have legends. References may be submitted in any style or format, as long as it is consistent throughout the manuscript. If the manuscript, figures or tables are difficult for you to read, they will also be difficult for the editors and reviewers. If your manuscript is difficult to read, the editorial office may send it back to you for revision.

Your co-author details, including affiliation and email address (please note, an institutional or professional email address is strongly recommended).

An ORCID ID, freely available at https://orcid.org.

If you are invited to revise your manuscript after peer review, the journal will also request the revised manuscript to be formatted according to journal requirements as described below.

Open Access

This journal is a subscription journal that offers an open access option. You’ll have the option to choose to make your article open access after acceptance, which will be subject to an APC. You can read more about APCs and whether you may be eligible for waivers or discounts, through your institution, funder, or a country waiver.

Preprint policy:

Please find the Wiley preprint policy here.

Drug Development Research will consider for review articles previously available as preprints. You may also post the submitted version of a manuscript to a preprint server at any time. You are requested to update any pre-publication versions with a link to the final published article.

Data Sharing and Data Availability

This journal expects data sharing. Review Wiley’s Data Sharing policy where you will be able to see and select the data availability statement that is right for your submission.

Data Citation

Please review Wiley’s Data Citation policy.

Funding

You should list all funding sources in the Acknowledgments section. Authors are responsible for the accuracy of their funder designation. If in doubt, please check the Open Funder Registry for the correct nomenclature.

ORCID

This journal requires ORCID for the corresponding author. Please refer to Wiley’s resources on ORCID.

Reproduction of Copyright Material

If excerpts from copyrighted works owned by third parties are included, credit must be shown in the contribution. It is your responsibility to also obtain written permission for reproduction from the copyright owners. For more information visit Wiley’s Copyright Terms & Conditions FAQ.

The corresponding author is responsible for obtaining written permission to reproduce the material "in print and other media" from the publisher of the original source, and for supplying Wiley with that permission upon submission.

Main Text File

The main text file should be in Word, PDF, or LaTeX format and include:

A short informative title containing the major key words. The title should not contain abbreviations

The full names of the authors with institutional affiliations where the work was conducted, with a footnote for the author’s present address if different from where the work was conducted;

Acknowledgments;

Abstract;

Up to three keywords;

Main body: formatted as introduction, materials & methods, results, discussion, conclusion;

References;

Tables (each table complete with title and footnotes);

Figures: Figure legends must be added beneath each individual image during upload AND as a complete list in the text.

刊知网 精心整理,转载请注明出处:https://www.kanzhiwang.com/archives/49843

我要点评 请您把投稿经验分享出来 让大家少走弯路少踩坑,我为人人、人人为我。

内容纠错 您如果发现杂志信息有错漏 可以在下方留言。

上一篇 2024年11月9日 下午12:53
下一篇 2024年11月9日 下午12:53

相关推荐

发表回复

登录后才能评论

联系我们

191 1833 1195

在线咨询: QQ交谈

邮件:321628655@qq.com

工作时间:周一至周五,9:30-18:30,节假日休息